Rabies prophylaxis vaccines are in short supply

09/21/2012 | NBC News

Manufacturers of rabies post-exposure prophylaxis vaccines, used yearly to treat some 23,000 to 38,000 potentially exposed Americans, have reported low stock of the vaccines. That's concerning to health officials because this year's tally of rabies cases in animals is higher than normal and human exposures are up. "It's a little worrisome. It makes us even more cautious," said New Mexico's state public health veterinarian Paul Ettestad. "Usually we keep enough vaccine on hand for 10 people, and right now we have enough only for three or four." Production of the vaccines is under way and colder weather should slow the virus, so experts expect supplies to rebound soon.

View Full Article in:

NBC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations